1. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie;Al-Batran;J. Clin. Oncol.,2008
2. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory;Arnold;Eur. J. Cancer,2015
3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial;Bang;Lancet,2010
4. Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: Primary analysis of JAVELIN Gastric 300;Bang;Ann. Oncol.,2018
5. Comprehensive molecular characterization of gastric adenocarcinoma;Bass;Nature,2014